Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Corey Stephen Cutler, M.D.

Co-Author

This page shows the publications co-authored by Corey Cutler and Nathaniel Treister.
Connection Strength

3.742
  1. Topical sirolimus for management of refractory oral chronic graft-versus-host disease. Oral Dis. 2021 Sep; 27(6):1451-1454.
    View in: PubMed
    Score: 0.934
  2. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium. Bone Marrow Transplant. 2013 Aug; 48(8):1123-8.
    View in: PubMed
    Score: 0.546
  3. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant. 2010 Jan; 16(1):108-14.
    View in: PubMed
    Score: 0.433
  4. Use of Prescription Sialagogues for Management of Xerostomia in Chronic Graft-versus-Host-Disease. Transplant Cell Ther. 2021 06; 27(6):480.e1-480.e5.
    View in: PubMed
    Score: 0.239
  5. Long-Term Utilization Patterns of Topical Therapy and Clinical Outcomes of Oral Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020 02; 26(2):373-379.
    View in: PubMed
    Score: 0.217
  6. Economic and Practical Considerations in the Treatment of Oral Mucosal Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1748-1753.
    View in: PubMed
    Score: 0.194
  7. An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2016 11; 22(11):2084-2091.
    View in: PubMed
    Score: 0.175
  8. Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium. Oral Dis. 2016 Apr; 22(3):235-40.
    View in: PubMed
    Score: 0.168
  9. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life. Oral Oncol. 2015 Oct; 51(10):944-9.
    View in: PubMed
    Score: 0.163
  10. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Mar; 21(3):503-8.
    View in: PubMed
    Score: 0.155
  11. How we treat oral chronic graft-versus-host disease. Blood. 2012 Oct 25; 120(17):3407-18.
    View in: PubMed
    Score: 0.132
  12. Medical management update: Non-Hodgkin lymphoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan; 107(1):e19-33.
    View in: PubMed
    Score: 0.103
  13. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006 Jul 15; 108(2):756-62.
    View in: PubMed
    Score: 0.085
  14. Oral health in allogeneic hematopoietic stem cells transplantation survivors. Bone Marrow Transplant. 2020 11; 55(11):2211-2214.
    View in: PubMed
    Score: 0.057
  15. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018 06; 81:1-9.
    View in: PubMed
    Score: 0.049
  16. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015 Mar; 21(3):389-401.e1.
    View in: PubMed
    Score: 0.039
  17. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011 Dec 01; 365(22):2055-66.
    View in: PubMed
    Score: 0.032
  18. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. 2006 Apr; 12(4):375-96.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.